Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)
Название протокола
Клинические исследование Rheumatoid Arthritis (RA): ABBV-154, Placebo - Реестр клинических исследований
